PT - JOURNAL ARTICLE AU - Dawa Sherpa TI - Estimating Impact of Austerity policies in COVID-19 fatality rates: Examining the dynamics of economic policy and Case Fatality Rates (CFR) of COVID-19 in OECD countries AID - 10.1101/2020.04.03.20047530 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.03.20047530 4099 - http://medrxiv.org/content/early/2020/04/13/2020.04.03.20047530.short 4100 - http://medrxiv.org/content/early/2020/04/13/2020.04.03.20047530.full AB - The paper will attempt to estimate factors which determine the variability of case fatality rates of COVID-19 across OECD countries in the recent time. The objective of the paper is to estimate the impact of government health policies on fatality rates (Case fatality rates) of COVID-19 in_OECD countries while controlling for other demographic and economic characteristics. The analysis is done using non-parametric regression method, i.e. Quantile regression. The result from quantile regression analysis shows that a policy of Austerity (health expenditure cuts) significantly increases the mortality rates of COVID-19 in OECD countries. The policy implication of the study is the need for a robust public-funded health system with wider accessibility to deal with major public health crisis like COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received by the authors or their institutions at any time received payment or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearch is based on secondary data which is publicly available. https://www.oecd.org/health/health-data.htm https://www.who.int/data/gho/data/indicators